2017
DOI: 10.1016/j.bbagen.2016.10.026
|View full text |Cite
|
Sign up to set email alerts
|

Existence of muscarinic acetylcholine receptor (mAChR) and fibroblast growth factor receptor (FGFR) heteroreceptor complexes and their enhancement of neurite outgrowth in neural hippocampal cultures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
50
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 41 publications
(51 citation statements)
references
References 64 publications
0
50
1
Order By: Relevance
“…Although a specific investigation is needed to identify the type of mAChR involved, by literature data and our experience we can hypothesize some possibilities involving M 1 R or M 3 R receptors. Previously, we showed that M 1 R are involved in FGFR1 transactivation in Oxo treatment‐induced neuronal axonal growth (Di Liberto, Borroto‐Escuela, et al, ). Recently, it has been shown that M 3 R activation leads to enhancement of Hsp70 and Hsp90 expression and phosphorylation of HSF1 (Mahati et al, ).…”
Section: Discussionmentioning
confidence: 93%
See 2 more Smart Citations
“…Although a specific investigation is needed to identify the type of mAChR involved, by literature data and our experience we can hypothesize some possibilities involving M 1 R or M 3 R receptors. Previously, we showed that M 1 R are involved in FGFR1 transactivation in Oxo treatment‐induced neuronal axonal growth (Di Liberto, Borroto‐Escuela, et al, ). Recently, it has been shown that M 3 R activation leads to enhancement of Hsp70 and Hsp90 expression and phosphorylation of HSF1 (Mahati et al, ).…”
Section: Discussionmentioning
confidence: 93%
“…Additionally, in order to unveil a temporal behavior of the Oxo effect within each type of treatment, we analyzed a time-course with three time points: 24, 48, and 72 hr from treatment, with exclusion of 10 days treatment in which we analyzed the time points 24 and 72 hr from treatment. For the single injection, we chose the Oxo dose of 0.4 mg/kg and for chronic treatment the dose of 0.2 mg/kg in relation to previous experience (Di Liberto, Frinchi, et al, 2017).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently identified direct interactions with RTK (BorrotoEscuela et al, 2012;Di Liberto et al, 2017), indeed, open the possibility that GPCR complexes could modulate structural changes at the level of dendrites and dendritic spines. Furthermore, the reorganization of GPCR complexes in the postjunctional membrane of synapses and their possible stabilization by the interaction with specific adapter proteins could represent a molecular mechanism for learning and memory Fuxe et al, 2014b;Borroto-Escuela et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…Processes of transactivation of RTK by GPCR have been reported (Flajolet et al, 2008;Asimaki et al, 2011;Di Liberto et al, 2014), generating neuroplasticity in cultured neurons. Recently, however, the formation (by direct RRI) of receptor complexes involving fibroblast growth factor receptor 1 and 5-HT 1A or muscarinic M 1 receptor (Di Liberto et al, 2017) have been identified in the hippocampus with increased neurite densities after agonist coactivation.…”
Section: Rm and Hmnsmentioning
confidence: 99%